Recent developments in vaccine research:Novel platforms and applications in global health

Sina Salem Ahim; Mahnaz  Mohammadnezhad; Nilufar  Bavafa

doi:10.61882/jcbior.6.4.339

Authors

Sina Salem Ahim School of Medicine, Fasa University of Medical Sciences, Fasa, Iran https://orcid.org/0009-0008-2452-434X
Mahnaz Mohammadnezhad Department of Midwifery, School of Nursing and Midwifery, Ardabil University of Medical Sciences, Ardabil, Iran https://orcid.org/0000-0003-1041-2837
Nilufar Bavafa Department of Food Microbiology, Sanjesh Zagros Mokrian Laboratory, Mahabad, Iran

DOI:

https://doi.org/10.61882/jcbior.6.4.339

Keywords:

Vaccine platforms, mRNA vaccines, Viral vector vaccines, Protein subunit vaccines, Immunization strategies

Abstract

No abstract.

References

1. Bok K, Sitar S, Graham BS, Mascola JR. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. Immunity. 2021;54(8):1636-1651.

DOI: 10.1016/j.immuni.2021.07.017 PMID: 34348117

2. Ghattas M, Dwivedi G, Lavertu M, Alameh MG. Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities. Vaccines (Basel). 2021;9(12):1490.

DOI: 10.3390/vaccines9121490 PMID: 34960236

3. Kennedy RB, Ovsyannikova IG, Palese P, Poland GA. Current Challenges in Vaccinology. Front Immunol. 2020;11:1181.

DOI: 10.3389/fimmu.2020.01181 PMID: 32670279

4. Gebre MS, Brito LA, Tostanoski LH, Edwards DK, Carfi A, Barouch DH. Novel approaches for vaccine development. Cell. 2021;184(6):1589-1603.

DOI: 10.1016/j.cell.2021.02.030 PMID: 33740454

5. Lu B, Lim JM, Yu B, Song S, Neeli P, Sobhani N, et al. The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects. Front Immunol. 2024;15:1332939.

DOI: 10.3389/fimmu.2024.1332939 PMID: 38361919

6. Katoto PD, Tamuzi JL, Brand AS, Marangu DM, Byamungu LN, Wiysonge CS, et al. Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis. Hum Vaccin Immunother. 2023;19(1):2214495.

DOI: 10.1080/21645515.2023.2214495 PMID: 37277959

7. Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261-279. DOI: 10.1038/nrd.2017.243 PMID: 29326426

8. Saxena S, Mandrah V, Tariq W, Das P, Sambhav K, Devi SH. The Future of mRNA Vaccines: Potential Beyond COVID-19. Cureus. 2025;17(5):e84529.

DOI: 10.7759/cureus.84529 PMID: 40546533

9. Vanaparthy R, Mohan G, Vasireddy D, Atluri P. Review of COVID-19 viral vector-based vaccines and COVID-19 variants. Infez Med. 2021;29(3):328-338. DOI: 10.53854/liim-2903-3 PMID: 35146337

10. Marzi A, Feldmann F, O'Donnell KL, Hanley PW, Messaoudi I, Feldmann H. Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus-Based Filovirus Vaccines in Nonhuman Primates. J Infect Dis. 2023;228(Suppl 7):S671-S676. DOI: 10.1093/infdis/jiad208 PMID: 37290042

11. Bayani F, Hashkavaei NS, Arjmand S, Rezaei S, Uskoković V, Alijanianzadeh M, et al. An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines. Prog Biophys Mol Biol. 2023;178:32-49.

DOI: 10.1016/j.pbiomolbio.2023.02.004 PMID: 36801471

12. Kheirvari M, Liu H, Tumban E. Virus-like Particle Vaccines and Platforms for Vaccine Development. Viruses. 2023;15(5):1109. DOI: 10.3390/v15051109 PMID: 37243195

13. Li J, Liu D, Li X, Wei J, Du W, Zhao A, et al. RNA vaccines: The dawn of a new age for tuberculosis? Hum Vaccin Immunother. 2025;21(1):2469333. DOI: 10.1080/21645515.2025.2469333 PMID: 40013818

14. Hu Z, Lu SH, Lowrie DB, Fan XY. Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development. Front Immunol. 2022;13:895020.

DOI: 10.3389/fimmu.2022.895020 PMID: 35812383